drugset / Trial / NCT00239876

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

NCT00239876

Phase 3 Completed 140 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the safety and efficacy of FTY720 combined with tacrolimus and corticosteroids in patients receiving a kidney transplant

Timeline

Start
2005-05
Primary completion
2005-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fingolimod Small molecule

Indications

No indication recorded.